Reversion of malignant phenotype with 9-hydroxy ellipticine derivatives
Details for Australian Patent Application No. 2007252982 (hide)
International Classifications
Event Publications
11 December 2008 PCT application entered the National Phase
PCT publication WO2007/135538 Priority application(s): WO2007/135538
23 August 2012 Application Accepted
Published as AU-B-2007252982
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007252986-Progastrin inhibitors in the treatment of colon cancer
2007252967-A composition for inactivating an enveloped virus
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser